My Co-Pay Accumulator Story
“Important Prescription Plan Change,” the letter announced. “We’re writing to inform you of an important upcoming change to your specialty prescription benefits.”
A “Favourite” Film Spotlights Gout
A darling of Hollywood’s movie awards season is inviting discussion on an unexpected topic: gout.
ICER vs. Infants
An incomplete and poorly conceived report from the controversial Institute for Clinical and Economic Review has set its sights on a most unbecoming target: infants with a degenerative, life-threatening neurological condition.
Watching, Waiting for Access in Puerto Rico
While some hepatitis C patients stateside are rejoicing at newly-relaxed barriers to curative treatment, those covered by Medicaid in Puerto Rico must watch and wait.
Health Plans’ Prescribing Restrictions Undercut Migraine Treatment
On top of debilitating pain and widespread stigma, patients with migraine now face another challenge. If they want preventive treatment, they must first find a physician that their health plan will allow to prescribe it.
The Orphan Drug Disconnect
Decades after Congress passed the Orphan Drug Act, only about 10 percent of patients with rare diseases actually receive treatment with orphan drugs, a new report finds.
What’s Human Milk Good For?
Dubbed “liquid gold,” human milk offers a nutritional elixir for infants. And that has researchers asking an intriguing question: How else could human milk be used to optimize health?
2018 in Review: 6 Trends that Impacted Patient Access
Before ringing in the new year, the Institute for Patient Access takes a look back at the policy trends that shaped health care access in 2018.
New Medicare Cost-Cutting Proposal Would Hurt Older Adults but Recognizing Pharmacists would Help
The newest proposal to cut prescription drug costs could strip important protections for already vulnerable patients, especially those living in long-term care facilities.
New IfPA Policy Paper Warns about Non-Medical Switching of Botulinum Neurotoxins
Patients with a range of conditions from chronic migraine to overactive bladder can achieve relief from a medication called a “botulinum neurotoxin.”
